Lobbying Relationship

Client

International Myeloma Foundation

More records

Lobbying firm

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

More records

  • S. 2039, the Cancer Drug Parity Act; Cancer Moonshot
  • FY24 Labor Health Human Services and Related Agencies

Duration: to

General Issues: Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs

Spending: about $850,000 (But it's complicated. Here's why.)

Agencies lobbied since 2011: U.S. Senate, House of Representatives, White House Office, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH)

Bills mentioned

H.R.2739: Cancer Drug Coverage Parity Act of 2015

Sponsor: Leonard Lance (R-N.J.)

S.1566: Cancer Drug Coverage Parity Act of 2015

Sponsor: Mark Steven Kirk (R-Ill.)

H.RES.174: Expressing support for designation of March as "National Multiple...

Sponsor: Brian Higgins (D-N.Y.)

H.R.1801: Cancer Drug Coverage Parity Act of 2013

Sponsor: Brian Higgins (D-N.Y.)

S.1879: Cancer Treatment Parity Act of 2013

Sponsor: Al Franken (D-Minn.)

H.R.2477: Planning Actively for Cancer Treatment (PACT) Act of 2013

Sponsor: Lois Capps (D-Calif.)

H.R.2827: Part D Beneficiary Appeals Fairness Act

Sponsor: Hank Johnson (D-Ga.)

H.R.543: Blue Water Navy Vietnam Veterans Act of 2013

Sponsor: Chris Gibson (R-N.Y.)

H.R.1491: To authorize the Administrator of the National Oceanic and Atmospheric...

Sponsor: Suzanne Bonamici (D-Ore.)

S.1284: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Tom Harkin (D-Iowa)

H.R.2410: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Robert B. Aderholt (R-Ala.)

S.1244: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Mark Pryor (D-Ark.)

S.2844: James Zadroga 9/11 Health and Compensation Reauthorization Act

Sponsor: Kirsten E. Gillibrand (D-N.Y.)

H.R.5503: James Zadroga 9/11 Health and Compensation Reauthorization Act

Sponsor: Carolyn B. Maloney (D-N.Y.)

H.R.4800: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Robert B. Aderholt (R-Ala.)

S.2389: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Mark Pryor (D-Ark.)

H.R.83: Consolidated and Further Continuing Appropriations Act, 2015

Sponsor: Donna M.C. Christensen (D-Virgin Islands)

H.R.3204: Drug Quality and Security Act

Sponsor: Fred Upton (R-Mich.)

S.959: Pharmaceutical Quality, Security, and Accountability Act

Sponsor: Tom Harkin (D-Iowa)

H.R.2746: Cancer Drug Coverage Parity Act of 2011

Sponsor: Brian Higgins (D-N.Y.)

S.3295: Departments of Labor, Health and Human Services, and Education, and...

Sponsor: Tom Harkin (D-Iowa)

H.R.2245: Preserving Access to Life-Saving Medications Act of 2011

Sponsor: Diana DeGette (D-Colo.)

S.296: Preserving Access to Life-Saving Medications Act

Sponsor: Amy Klobuchar (D-Minn.)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.4385: Cancer Drug Parity Act of 2021

Sponsor: Brian Higgins (D-N.Y.)

S.3080: Cancer Drug Parity Act of 2021

Sponsor: Tina Smith (D-Minn.)

S.2039: Cancer Drug Parity Act of 2023

Sponsor: Tina Smith (D-Minn.)

H.R.6301: Cancer Drug Parity Act of 2023

Sponsor: Glenn Grothman (R-Wis.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Johanna Gray Intern, Sen. Barack Obama intern, Sen. Barack Obama
Jenifer Leib Policy Fellow, NIH/NHGRI Office of the Director
Jennifer Leib Policy Fellow, NIH/NHGRI Office of the Director
Nicholas G Cavarocchi n/a
Nicholas G. Cavarocchi n/a
Tiffany Kaszuba n/a
Jeremy Scott n/a
Lindsey Trischler n/a
Grace Kranstover n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Registration
Termination
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Registration
Amendment
Amendment
Q1 Report
Registration
Termination
Termination
Registration
Amendment
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page